ArticleActa orthopaedica2026
No difference in patient-reported outcome measures between private and public hospitals in the Netherlands: a cross-sectional analysis based on 170,150 hip and knee arthroplasties from the Dutch Arthroplasty Register.
Article in Acta orthopaedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposePrivate hospitals have become more frequent healthcare providers for arthroplasty surgery in the Netherlands. The aim of our study was to assess patient-reported outcome measures (PROMs) in patients who received primary total hip arthroplasty (THA), total knee arthroplasty (TKA), and unicompartmental knee arthroplasty (UKA) in private hospitals compared with patients from public hospitals, and to assess access to care based on mean travel distance to the healthcare facility.
methodsPatients operated on between 2014 and 2023 were included. Patient characteristics, preoperative, 3- or 6-, and 12 months postoperative PROMs (Numeric Pain Rating Scale [NRS] pain, EuroQoL 5-Dimensions [EQ-5D-5L], Hip disability and Osteoarthritis Outcome Score [HOOS-PS], Knee Injury and Osteoarthritis Outcome Score [KOOS-PS], Oxford Hip Score [OHS], and Oxford Knee Score [OKS]) were retrieved from the LROI. For analysis, repeated measurements were performed, using mixed-effect models adjusted for confounders. Primary endpoints for inference were NRS pain during activity, HOOS/KOOS-PS, and OHS/OKS at 3 months follow-up. Mean travel distance to the hospital was compared, as measure for access to care.
results146,303 primary THAs, TKAs, and UKAs performed in public hospitals and 23,847 in private hospitals were included. Patients undergoing arthroplasty in private hospitals were generally younger and had a higher socioeconomic status and lower body mass index and American Society of Anesthesiologists Physical Status class. Both patients from private and public hospitals improved similarly and significantly after surgery. At 3-month follow-up, public hospitals showed marginal but statistically significant advantages in HOOS/KOOS-PS for THA, TKA, and UKA (mean differences 0.5 [95% confidence interval (CI) 0.1-0.9], 0.5 [CI 0.1-0.9], and 1.3 [CI 0.5-2.1], respectively). OKS favored public hospitals for TKA and UKA (-0.4 [CI -0.6 to -0.2] and -0.6 [CI -1.0 to -0.1]). NRS pain during activity favored private hospitals for TKA (-0.2 [CI -0.3 to -0.1]). All absolute differences were small and without statistical significance. Mean travel distance was significantly shorter for patients treated in public hospitals.
conclusionThere is no difference in PROMs between public and private hospitals after primary THA, TKA and UKA in the Netherlands. Based on mean travel distance, access to care was not compromised for high-risk patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.